Condensed Balance Sheets - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 3,218,067	$ 3,451,761
Accounts receivable, net	254,584	488,373
Inventory	5,232,738	3,046,323
Prepaid and other current assets	1,045,591	1,035,993
Total current assets	9,750,980	8,022,450
Property and equipment, at cost:
Leasehold improvements	1,238,886	1,238,886
Office equipment	68,530	60,921
Furniture and fixtures	417,876	417,876
Machinery and equipment	3,211,109	2,856,740
Construction in progress	548,426	762,445
Property and equipment, gross	5,484,827	5,336,868
Less accumulated depreciation	(3,884,964)	(3,740,769)
Net property and equipment	1,599,863	1,596,099
Long-term assets:
Lease right-of-use assets, net	1,544,724	1,805,543
Intangible assets, net of accumulated amortization	55,638	65,918
Other long-term assets	829,204	954,992
Total long-term assets	2,429,566	2,826,453
Total assets	13,780,409	12,445,002
Current liabilities:
Accounts payable	3,263,584	1,419,044
Accrued expenses	1,052,752	1,151,049
Convertible notes payable, net (including related parties)	6,080,813	5,406,228
Clinical holdback – current portion	63,990	88,581
Operating lease liabilities – current portion	502,468	517,967
Total current liabilities	10,963,607	8,582,869
Long-term liabilities:
Clinical holdback – long-term portion	40,348	39,611
Lease liabilities – long-term portion	1,269,019	1,518,100
Total long-term liabilities	1,309,367	1,557,711
Total liabilities	12,272,974	10,140,580
Commitments and contingencies
Stockholders’ equity:
Common stock, $.001 par, 200,000,000 authorized, 32,692,630 shares issued and 32,575,407 outstanding as of June 30, 2025; and 23,473,149 shares issued and 23,355,926 outstanding as of December 31, 2024	32,693	23,473
Treasury stock, 117,223 common shares	(60,000)	(60,000)
Warrants	1,821,744	1,860,008
Additional paid-in-capital	137,394,016	127,679,198
Accumulated deficit	(137,681,018)	(127,198,257)
Total stockholders’ equity	1,507,435	2,304,422
Total liabilities and stockholders’ equity	$ 13,780,409	$ 12,445,002